Table 3.
Multivariate GEE analysis of eGFR and AP0L1 risk status adjusting for histopath, age, baseline UPC, and RAAS blockade
| Covariate | β | 95% CI | P Value |
|---|---|---|---|
| HR | −17.2 | –29.0 to 5.4 | <0.01 |
| Histopath | |||
| FSGS | ref | — | — |
| MCD | 22.0 | 6.7 to 37.2 | <0.01 |
| MN | 8.5 | –8.9 to 25.9 | 0.34 |
| Other | −1.4 | –15.8 to 13.1 | 0.85 |
| Age (y) | −1.1 | –1.4 to –0.7 | <0.01 |
| UPC baseline | −0.8 | –1.6 to 0.0 | 0.04 |
| RAAS | 2.6 | –3.7 to 8.9 | 0.42 |
Parameter estimates and P values determined using GEEs. Other, other glomerulopathies; Age, patient age at enrollment; ref, reference; 95% CI, 95% confidence interval.